EKF Diagnostics - Admiral brand disposal

Monday, Jan 03 2011 by
1

EKF Diagnostics, the buy and build Point of Care (PoC) diagnostics company led by Julian Baines and David Evans, announced that it has completed the disposal of the Admiral sportswear brand for about £830,000 cash. £83,000 will be paid on completion, with the balance to be paid before the end of January 2011. EKF has raised c. £1.8 million in 2010 through the Admiral disposal. The proceeds from the disposal will be used to support the current diagnostics business.


Disclaimer:  

This note was prepared by LCF Research Limited using information provided by the subject company’s management or publically available news sources. No representations are made nor warranties given (express or implied) in relation to accuracy and completeness. This document is not an invitation to invest in the subject company and does not purport to contain all the necessary information that a prospective investor might require. LCF Research Limited recommends prospective investors to conduct their own thorough independent analysis of the subject company and the information contained in this note or referred to above.


Do you like this Post?
Yes
No
1 thumb up
0 thumbs down
Share this post with friends



EKF Diagnostics Holdings Plc is focused on the In-Vitro Diagnostic device (IVD) market place. The Company is engaged in the designing, development, manufacture and selling of diagnostic instruments, reagents and certain ancillary products. This activity takes place across various geographical locations which include the United States America, Germany, Poland, Russia, United Kingdom and Ireland. The Company’s segments include the manufacture and sale of medical diagnostic equipment. Other services include the servicing and distribution of third party company products under separate distribution agreements. In March 2014, EKF Diagnostics Holdings PLC acquired Separation Technology Inc. The subsidiaries include: EKF Diagnostics Limited; Quotient Diagnostics Limited; EKF-diagnostic GmbH Germany; Senslab GmbH 2; EKF Diagnostyka Sp.z.o.o. ;EKF Diagnostika ; EKF Diagnostics Inc ; Stanbio Laboratory LP ; Stanbio Life Sciences LP ; EKF Diagnostics Limited, and 360 Genomics Limited. more »

Share Price (AIM)
22.38p
Change
0.6%
Mkt Cap (£m)
94.4
P/E (fwd)
n/a
Yield (fwd)
n/a



  Is EKF Diagnostics Holdings fundamentally strong or weak? Find out More »


What's your view on this thread? Log In to Comment Now

You can track all @StockoChat comments via Twitter




Stock Picking Tutorial Centre


Related Content

Stock Picking Simplified

Stockopedia takes your stock picking to the next level with cutting edge Stock Reports & Screening tools.


Get started
or Take a Tour to find out more.
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis
Foliobuilder